444 related articles for article (PubMed ID: 15925452)
1. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.
Zagars GK; Pollack A
Urology; 1995 Mar; 45(3):476-83. PubMed ID: 7533459
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
Zagars GK; Pollack A; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer.
Zagars GK; Pollack A; Kavadi VS; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):293-306. PubMed ID: 7538498
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical and prostate-specific antigen follow-up in 500 patients treated with radiation therapy for localized prostate cancer.
Aygun C; Blum J; Stark L
Md Med J; 1995 May; 44(5):363-8. PubMed ID: 7539518
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer.
Pollack A; Zagars GK; Kopplin S
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):13-20. PubMed ID: 7536720
[TBL] [Abstract][Full Text] [Related]
7. Prostate specific antigen following radiotherapy for local prostate cancer.
Rosenzweig KE; Morgan WR; Lytton B; Peschel RE
J Urol; 1995 May; 153(5):1561-4. PubMed ID: 7536267
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer.
Kuban DA; el-Mahdi AM; Schellhammer PF
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):307-16. PubMed ID: 7538499
[TBL] [Abstract][Full Text] [Related]
9. The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome.
Zietman AL; Coen JJ; Dallow KC; Shipley WU
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):287-92. PubMed ID: 7751173
[TBL] [Abstract][Full Text] [Related]
10. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients.
Crook JM; Perry GA; Robertson S; Esche BA
Urology; 1995 Apr; 45(4):624-31; discussion 631-2. PubMed ID: 7716843
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for regionally localized hormone refractory prostate cancer.
Lankford SP; Pollack A; Zagars GK
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):907-12. PubMed ID: 7591901
[TBL] [Abstract][Full Text] [Related]
12. Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment.
Corn BW; Hanks GE; Schultheiss TE; Hunt MA; Lee WR; Coia LR
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):325-30. PubMed ID: 7503847
[TBL] [Abstract][Full Text] [Related]
13. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy.
Bales GT; Williams MJ; Sinner M; Thisted RA; Chodak GW
Urology; 1995 Nov; 46(5):676-80. PubMed ID: 7495120
[TBL] [Abstract][Full Text] [Related]
14. [Long-term follow-up of serum prostate-specific antigen after radiotherapy of prostatic carcinoma].
Schmid HP; Ferrari MK; Stamey TA
Helv Chir Acta; 1994 Dec; 60(6):1101-5. PubMed ID: 7533148
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the urinary bladder: long-term results of interstitial radiotherapy.
Lybeert ML; Ribot JG; de Neve W; Goor C; Crommelin MA
Bull Cancer Radiother; 1994; 81(1):33-40. PubMed ID: 7893521
[TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen regression and progression after androgen deprivation for localized and metastatic prostate cancer.
Fowler JE; Pandey P; Seaver LE; Feliz TP; Braswell NT
J Urol; 1995 Jun; 153(6):1860-5. PubMed ID: 7538599
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen.
Wu JJ; King SC; Montana GS; McKinstry CA; Anscher MS
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):317-23. PubMed ID: 7538500
[TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen levels during and after external beam radiotherapy for localized carcinoma of the prostate: predictor of therapeutic efficacy.
Rodrigus P; van Landeghem AA
Strahlenther Onkol; 1992 Jul; 168(7):397-401. PubMed ID: 1379747
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen progression rates after radical prostatectomy or radiation therapy for localized prostate cancer.
Fowler JE; Pandey P; Braswell NT; Seaver L
Surgery; 1994 Aug; 116(2):302-5; discussion 305-6. PubMed ID: 7519363
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy of localized prostate cancer.
Landmann C
Ann Urol (Paris); 1994; 28(4):207-20. PubMed ID: 7979211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
